<DOC>
	<DOCNO>NCT00598715</DOCNO>
	<brief_summary>For lesion develop restenosis drug-eluting stent , know right strategy use , implantation type DES initial one DES different drug .</brief_summary>
	<brief_title>Efficacy Study Two Different Strategies Restenosis Sirolimus-Eluting Stents</brief_title>
	<detailed_description>Treatment in-stent restenosis implantation DES poorly study . Although data , may assume certain lesion might resistant give drug need different DES . Thus , lesion develop restenosis DES , know right strategy use , implantation type DES initial one DES different drug . This prospective , randomized trial compare anti-restenotic efficacy PES SES patient restenosis initial implantation SES</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Patients old age 18 ischemic symptom evidence myocardial ischemia presence &gt; 50 % stenosis prior implantation Sirolimus elute stent native coronary vessel Written , inform consent patient her/his legallyauthorized representative participation study In woman childbearing potential negative pregnancy test mandatory Cardiogenic shock Acute myocardial infarction within first 48 hour symptom onset . Target lesion locate leave main trunk bypass graft . Malignancies comorbid condition ( example severe liver , renal pancreatic disease ) life expectancy le 12 month may result protocol noncompliance . Allergy antiplatelet therapy , sirolimus , paclitaxel , stainless steel . Pregnancy ( present , suspected plan ) positive pregnancy test . Previous enrollment trial . Patient 's inability fully comply study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>In-stent restenosis</keyword>
	<keyword>In-DES-restenosis</keyword>
	<keyword>paclitaxel</keyword>
	<keyword>sirolimus</keyword>
</DOC>